Özlem AYNACI, Lasif SERDAR, Sema RAKICI, Seher KAZAZ, Emine CANYILMAZ, Zümrüt BAHAT, Ahmet Yaşar ZENGİN

Radiotherapy in Cancer Treatment During The Covid-19 Pandemic: One Year Results From Northeast Turkey

OBJECTIVE The goal of this article was to assess the effects and consequences of strict measures in radiation oncol- ogy centers in northeastern Turkey during the coronavirus disease-2019 pandemic and to ensure that the reorganization of programs occurred without interruption to radiotherapy (RT). METHODS We retrospectively reviewed the records of 1063 patients (median age 63 years; range 3-93 years) who were treated in RT centers from March 2020 to March 2021. The study cohort was divided into two groups: Group A consisted of patients who received RT in the first 6 months and Group B comprised patients who received RT in the second 6 months. RESULTS The age distribution was similar in both groups. The analysis of the intent of treatment showed that 585 (55%) patients were treated with a radical intent in Group A, whereas only 478 (45%) were treated with a radical intent in Group B. Lung, breast, and genitourinary cancers were the most common cancer types in both periods. There was a significant decline in the number of female patients in Group B. Test results of 31 (2.9%) patients, 8 (25.8%) women and 23 (74.2%) men, who had nasopharyngeal swabs, were positive. CONCLUSION This study shows that oncology patients in our region are more worried about disease progression than the pandemic and insist on going to RT, especially during the first 6-month period when the pandemic was thought to be temporary. As a result of careful precautions, treatments in the clinics continued without contamination.

PDF

___

1. WHO. Covid 19. https://www.euro.who.int/en/health- topics/health-emergencies/coronavirus-covid-19 Ac- cessed Oct 7, 2021.
2. Darıcı M. Roles of Science people in policy making processes: The example of the scientific committee formed in the scope of the combat against COVID-19. Tokat Gaziosmanpaşa Üniversitesi Sosyal Bilimler Araştırmaları Dergisi 2020;15:464–72.
3. Cander B, Yakıncı C. COVID-19 öyküleri. Malatya: İnönü Üniversitesi Yayınevi; 2020.
4. Anacak Y, Onal C, Ozyigit G, Agaoglu F, Akboru H, Akyurek S, et al.Changes in radiotherapy practice dur- ing COVID-19 outbreak in Turkey: A report from the Turkish Society for Radiation Oncology. Radiother Oncol 2020;150:43–5.
5. Gemici C, Yaprak G. Covid-19 outbreak in a major ra- diation oncology department; which lessons should be taken? Radiother Oncol 2020;149:107–8.
6. Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. Clin- ical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a sin- gle medical center, Wuhan, China. Int J Infect Dis 2020;94:128–32.
7. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) out- break. J Autoimmun 2020;109:102433.
8. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21(3):335–7.
9. Chen W, Su XY, Wang VJ, Wang EC, Xu R, Zhong S, et al. Novel Coronavirus international public health emergency: guidance on radiation oncology facility operation. Adv Radiat Oncol 2020;5(4):560–6.
10. Tey J, Ho S, Choo BA, Ho F, Yap SP, Tuan JKL, et al. Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore. Radiother Oncol 2020;148:189–93.
11. Aghili M, Ghalehtaki R, Mousavi Darzikolaee N, Ja- fari F, Moshtaghian M. Radiotherapy and COVID-19: Practical recommendations from iran. Radiother On- col 2020;149:70–1.
12. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inac- tivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo- controlled, phase 1/2 clinical trial. Lancet Infect Dis 2021;21(2):181–92.
13. Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 2020;369(6499):77–81.
14. Slotman BJ, Cremades V, Kirby AM, Ricardi U. Euro- pean radiation oncology after one year of COVID-19 pandemic. Clin Transl Radiat Oncol 2021;28:141–3.
15. Caravatta L, Rosa C, Di Sciascio MB, Tavella SA, Di Pilli A, Ursini LA, et al. COVID-19 and radiation on- cology: The experience of a two-phase plan within a single institution in central Italy. Radiat Oncol 2020;15:226.
16. Ghosh J, Ganguly S, Mondal D, Pandey P, Dabkara D, Biswas B. Perspective of oncology patients during covid-19 pandemic: a prospective observational study from India. JCO Glob Oncol 2020;6:844–51